A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT01853228 · TERMINATED
Trial details
- NCT number
- NCT01853228
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-22
- Primary completion
- 2017-08-28
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.